Navigation Links
Deadly Skin Cancer Bites the Rich Harder

According to a new study, skin cancer levels have shown a significant increase in Northern Ireland since the early 1990s and the disease is more likely to affect those living in more affluent areas . The study also revealed that men and older people are more prone to the disease.

Researchers, who looked at official cancer statistics for nearly 23,000 patients over a 12-year period, reported a 20 per cent increase in patients and a 62 per cent increase in skin cancer samples processed by pathology laboratories.

The figures also showed that the three most common skin cancers - basal cell carcinoma, squamous cell carcinoma and malignant melanoma accounted for 27 per cent of all male cancers and 26 per cent of all female cancers.

"These findings show that many patients will have more than one skin cancer, highlighting the need to analyse both patient numbers and sample numbers to provide an accurate picture of cancer levels" says co-author Dr Susannah Hoey from the Dermatology Department at the Royal Victoria Hospital, part of the Belfast Health and Social Care Trust.

"The three skin cancers we looked at all increased with age, with the exception of malignant melanomas, which showed a decrease in men aged 75 and over.And there was a link between more patients living in wealthier areas and increased levels of malignant melanomas and basal cell carcinomas," Hoey added.

The team looked at data collected by the Northern Ireland Cancer Registry, at Queen's University Belfast, from 1993 to 2004, analysing the records of patients diagnosed with the three most common skin cancers.

They found that men were 30 per cent more likely to suffer from basal cell carcinoma, the most common form of skin cancer, which affected some 1,444 people a year in Northern Ireland during the study period and accounted for 17 per cent of all reported cancers. And men were twice as likely to suffer from squamous cell
'"/>




Page: 1 2 3

Related medicine news :

1. Smoking and Breast Cancer - A Deadly Combination
2. Latest Findings On The Deadly Disease - SARS
3. Deadly Diarrhoea Vaccine – Trail Results Promising
4. Sharp Increase Of The Deadly Diseases In Delhi
5. Imported Plants Could Deadly Harbor Mosquitoes, Says Report
6. Deadly Kiss - Peanut allergy kills a teenager
7. Deadly abortion pill takes two more lives
8. Severe Urinary Infection Could Lead To Deadly Blood Clots
9. Hush…..A Deadly Killer on the Prowl in Rural Andhra Pradesh
10. New Vaccine To Combat The Deadly Marburg Virus
11. Smoking and Obesity- A Deadly Combination
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Deadly Skin Cancer Bites the Rich Harder

Breaking Medicine Technology:DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4659 1Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4659 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4659 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4659 4Natural born divers and the molecular traces of evolution 9035 1Natural born divers and the molecular traces of evolution 9035 2Reading the brain without poking it 9033 1Reading the brain without poking it 9033 2Reading the brain without poking it 9033 3Reading the brain without poking it 9033 4Reading the brain without poking it 9033 5